维普中文期刊产品整合服务
3篇 您的检索式:作者名="Rajderkar"
    题名 作者 年代 出处 被引量
1Diffusion‐weighted MRI for staging and evaluation of response in diffuse large B‐cell lymphoma: a pilot study显示文摘Marilyn J. Siegel Clint E. Jokerst Dhana Rajderkar Charles F. Hildebolt Sagun Goyal Farrokh Dehdashti Nina Wagner Johnston Barry A. Siegel 2014NMR Biomed2014,,:2
2Perfusion and permeability MR imaging of gliomas显示文摘Shiroishi MS Habibi M Rajderkar D 0,,:1
3Synthesis of cocrystals of sulfonyl urea class drug using suitable coformers for enhancement of aqueous solubility显示文摘The pharmaceutical cocrystals and its engineering is widely accepted phenomenon regarding to the enhancement of aqueous solubility of poorly soluble drugs. The pharmaceutical cocrystals have the great ability to improve the physicochemical properties of drug substance. Cocrystals are formed by the stoichiometric combination of drug substance and the coformer. The drug glimepiride is a third generation oral hypoglycemic sulfonylurea class. Glimepiride is a drug which is get classified as biopharmaceutical classification system (BCS) class II which indicates the glimepiride having low aqueous solubility and high permeability. Cocrystal engineering is a perfect way to increases glimepiride solubility without changing its therapeutic property. The cocrystals were synthesized by the solvent drop grinding as a green chemistry approach. The coformers used to form the cocrystals are succinic acid (SA), Theobromine (TB), caffeine (CF). The synthesized cocrystals are get characterized by vibrational spectroscopy, thermal analysis, molecular crystallography, and optical microscopy. The obtained results shows the formation of cocrystal phase between the drug glimepiride and its coformers.Santosh S. Chhajed Yatish R. Rajderkar Anjali B. Tajanpure Jayprakash B. Ugale Sanjay J. Kshirsagar 2019Journal of Pharmaceutical and Biopharmaceutical Research2019,1,2:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费